Cat. #154733
Anti-CD63 [LAMP3]
Cat. #: 154733
Sub-type: Primary antibody
Unit size: 100 ug
Availability: 3-4 weeks
Target: CD63
Class: Monoclonal
Application: ELISA ; IHC ; IP
Reactivity: Human
Host: Mouse
£300.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Institute: Netherlands Cancer Institute
Tool Details
*FOR RESEARCH USE ONLY
- Name: Anti-CD63 [LAMP3]
- Alternate name: Melanoma-Associated Antigen ME491; Tetraspanin-3; Granulophysin
- Tool sub type: Primary antibody
- Class: Monoclonal
- Conjugation: Unconjugated
- Molecular weight: 25 kDa
- Strain: Balb/c
- Reactivity: Human
- Host: Mouse
- Application: ELISA ; IHC ; IP
- Description: CD63 is a member of the transmembrane 4 superfamily, also known as the tetraspanin family. These proteins mediate signal transduction events that play a role in the regulation of cell development, activation, growth, and motility. CD63 is mainly associated with membranes of intracellular vesicles, although cell surface expression may be induced.
- Immunogen: Purified membranes of human melanoma cells
- Isotype: IgG1
- Myeloma used: P3X63Ag8
Target Details
- Target: CD63
- Molecular weight: 25 kDa
- Target background: CD63 is a member of the transmembrane 4 superfamily, also known as the tetraspanin family. These proteins mediate signal transduction events that play a role in the regulation of cell development, activation, growth, and motility. CD63 is mainly associated with membranes of intracellular vesicles, although cell surface expression may be induced.
Applications
- Application: ELISA ; IHC ; IP
Handling
- Format: Liquid
- Concentration: 0.9-1.1 mg/ml
- Unit size: 100 ug
- Storage buffer: PBS with 0.02% azide
- Storage conditions: -15° C to -25° C
- Shipping conditions: Shipping at 4° C
References
- Hagen et al. 1986. Histopathology. 10(7):689-700. PMID: 2427431.
- Palmer et al. 1985. Pathology. 17(2):335-9. PMID: 3900899.
- Vennegoor et al. 1985. Int J Cancer. 35(3):287-95. PMID: 3882581.
